Alvise Berti , Michele Tomasi , Isabella Pesce , Enrico Lista , Anna Guella , Roberto Bortolotti , Giuseppe Paolazzi , Sophie Hillion , Ulrich Specks , Guido Grandi , Divi Cornec
{"title":"确定人类骨髓中自反应蛋白酶 3+ B 细胞的中央耐受检查点。","authors":"Alvise Berti , Michele Tomasi , Isabella Pesce , Enrico Lista , Anna Guella , Roberto Bortolotti , Giuseppe Paolazzi , Sophie Hillion , Ulrich Specks , Guido Grandi , Divi Cornec","doi":"10.1016/j.jaut.2024.103330","DOIUrl":null,"url":null,"abstract":"<div><div>Major target antigens of ANCA-associated vasculitis (AAV) are myeloperoxidase (MPO) and proteinase 3 (PR3). High-affinity MPO- and PR3-ANCA immunoglobulins are produced by antigen-experienced, class-switched autoreactive B cells. To prevent autoreactivity, B cells are subjected to several self-tolerance checkpoints, from the early immature stages in the bone marrow (BM), collectively called “central tolerance”, to late mature stages, collectively called “peripheral tolerance”; the latter was recently elucidated for autoreactive PR3<sup>+</sup> B cells.</div><div>Here we investigated central tolerance controlling immature PR3<sup>+</sup>B cells in the BM before their migration into the periphery as transitional B cells. We applied an established flow cytometry-based method using labeled recombinant PR3 (rPR3) to identify the PR3<sup>+</sup>B cells to compare the phenotype of PR3<sup>+</sup>B cells in paired samples of BM mononuclear cells (BMMC) and peripheral blood mononuclear cells (PBMC) of non-vasculitis controls (No-AAV), and PBMC of patients with PR3-ANCA-associated vasculitis (PR3-AAV).</div><div>We observed that the proportion of PR3<sup>+</sup>B cells within BMMC was higher (median [IQR]; 1.98 % [1.77–2.75]) than within PBMC of No-AAV (0.9 % [0.63–1.44], p < 0.01 by paired comparison) and similar to their proportion within PBMC of patients with PR3-AAV (1.82 % [1.66–3.21]; p > 0.05). Within CD24<sup>++</sup>CD38<sup>++</sup> B cells, the subset of B cell migrating from BM to the periphery, BMMC contained a greater proportion of PR3<sup>+</sup>B cells as compared to PBMC in No-AAV (3.35 % [1.99–4.92] versus 1.23 % [0.62–1.55], p < 0.01), showing different surface markers of maturation (i.e. higher proportion of CD27<sup>−</sup>CD10<sup>+</sup> and lower expression of CD21, IgD, IgM). Importantly, we observed a significant decline of the PR3<sup>+</sup> fraction from the immature subset (IgD<sup>−</sup>IgM<sup>+</sup>; 2.80 % [1.23–4.02]) to the early transitional subset (IgD<sup>+</sup>IgM<sup>+</sup>; 1.76 % [0.96–2.68], p < 0.01) in BMMC, while no significant reduction was observed between the early transitional of BMMC and the transitional compartment of PBMC in No-AAV (1.26 % [0.62–1.56], p > 0.05).</div><div>In conclusion, to prevent PR3-related autoimmunity, autoreactive PR3<sup>+</sup>B cells pass a stringent selection in the BM, and their removal by central tolerance checkpoint activity occurs mainly between T1-like/immature to T2-like/early transitional B cells of BMMC.</div></div>","PeriodicalId":15245,"journal":{"name":"Journal of autoimmunity","volume":"149 ","pages":"Article 103330"},"PeriodicalIF":7.9000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow\",\"authors\":\"Alvise Berti , Michele Tomasi , Isabella Pesce , Enrico Lista , Anna Guella , Roberto Bortolotti , Giuseppe Paolazzi , Sophie Hillion , Ulrich Specks , Guido Grandi , Divi Cornec\",\"doi\":\"10.1016/j.jaut.2024.103330\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Major target antigens of ANCA-associated vasculitis (AAV) are myeloperoxidase (MPO) and proteinase 3 (PR3). High-affinity MPO- and PR3-ANCA immunoglobulins are produced by antigen-experienced, class-switched autoreactive B cells. To prevent autoreactivity, B cells are subjected to several self-tolerance checkpoints, from the early immature stages in the bone marrow (BM), collectively called “central tolerance”, to late mature stages, collectively called “peripheral tolerance”; the latter was recently elucidated for autoreactive PR3<sup>+</sup> B cells.</div><div>Here we investigated central tolerance controlling immature PR3<sup>+</sup>B cells in the BM before their migration into the periphery as transitional B cells. We applied an established flow cytometry-based method using labeled recombinant PR3 (rPR3) to identify the PR3<sup>+</sup>B cells to compare the phenotype of PR3<sup>+</sup>B cells in paired samples of BM mononuclear cells (BMMC) and peripheral blood mononuclear cells (PBMC) of non-vasculitis controls (No-AAV), and PBMC of patients with PR3-ANCA-associated vasculitis (PR3-AAV).</div><div>We observed that the proportion of PR3<sup>+</sup>B cells within BMMC was higher (median [IQR]; 1.98 % [1.77–2.75]) than within PBMC of No-AAV (0.9 % [0.63–1.44], p < 0.01 by paired comparison) and similar to their proportion within PBMC of patients with PR3-AAV (1.82 % [1.66–3.21]; p > 0.05). Within CD24<sup>++</sup>CD38<sup>++</sup> B cells, the subset of B cell migrating from BM to the periphery, BMMC contained a greater proportion of PR3<sup>+</sup>B cells as compared to PBMC in No-AAV (3.35 % [1.99–4.92] versus 1.23 % [0.62–1.55], p < 0.01), showing different surface markers of maturation (i.e. higher proportion of CD27<sup>−</sup>CD10<sup>+</sup> and lower expression of CD21, IgD, IgM). Importantly, we observed a significant decline of the PR3<sup>+</sup> fraction from the immature subset (IgD<sup>−</sup>IgM<sup>+</sup>; 2.80 % [1.23–4.02]) to the early transitional subset (IgD<sup>+</sup>IgM<sup>+</sup>; 1.76 % [0.96–2.68], p < 0.01) in BMMC, while no significant reduction was observed between the early transitional of BMMC and the transitional compartment of PBMC in No-AAV (1.26 % [0.62–1.56], p > 0.05).</div><div>In conclusion, to prevent PR3-related autoimmunity, autoreactive PR3<sup>+</sup>B cells pass a stringent selection in the BM, and their removal by central tolerance checkpoint activity occurs mainly between T1-like/immature to T2-like/early transitional B cells of BMMC.</div></div>\",\"PeriodicalId\":15245,\"journal\":{\"name\":\"Journal of autoimmunity\",\"volume\":\"149 \",\"pages\":\"Article 103330\"},\"PeriodicalIF\":7.9000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of autoimmunity\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0896841124001641\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of autoimmunity","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0896841124001641","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow
Major target antigens of ANCA-associated vasculitis (AAV) are myeloperoxidase (MPO) and proteinase 3 (PR3). High-affinity MPO- and PR3-ANCA immunoglobulins are produced by antigen-experienced, class-switched autoreactive B cells. To prevent autoreactivity, B cells are subjected to several self-tolerance checkpoints, from the early immature stages in the bone marrow (BM), collectively called “central tolerance”, to late mature stages, collectively called “peripheral tolerance”; the latter was recently elucidated for autoreactive PR3+ B cells.
Here we investigated central tolerance controlling immature PR3+B cells in the BM before their migration into the periphery as transitional B cells. We applied an established flow cytometry-based method using labeled recombinant PR3 (rPR3) to identify the PR3+B cells to compare the phenotype of PR3+B cells in paired samples of BM mononuclear cells (BMMC) and peripheral blood mononuclear cells (PBMC) of non-vasculitis controls (No-AAV), and PBMC of patients with PR3-ANCA-associated vasculitis (PR3-AAV).
We observed that the proportion of PR3+B cells within BMMC was higher (median [IQR]; 1.98 % [1.77–2.75]) than within PBMC of No-AAV (0.9 % [0.63–1.44], p < 0.01 by paired comparison) and similar to their proportion within PBMC of patients with PR3-AAV (1.82 % [1.66–3.21]; p > 0.05). Within CD24++CD38++ B cells, the subset of B cell migrating from BM to the periphery, BMMC contained a greater proportion of PR3+B cells as compared to PBMC in No-AAV (3.35 % [1.99–4.92] versus 1.23 % [0.62–1.55], p < 0.01), showing different surface markers of maturation (i.e. higher proportion of CD27−CD10+ and lower expression of CD21, IgD, IgM). Importantly, we observed a significant decline of the PR3+ fraction from the immature subset (IgD−IgM+; 2.80 % [1.23–4.02]) to the early transitional subset (IgD+IgM+; 1.76 % [0.96–2.68], p < 0.01) in BMMC, while no significant reduction was observed between the early transitional of BMMC and the transitional compartment of PBMC in No-AAV (1.26 % [0.62–1.56], p > 0.05).
In conclusion, to prevent PR3-related autoimmunity, autoreactive PR3+B cells pass a stringent selection in the BM, and their removal by central tolerance checkpoint activity occurs mainly between T1-like/immature to T2-like/early transitional B cells of BMMC.
期刊介绍:
The Journal of Autoimmunity serves as the primary publication for research on various facets of autoimmunity. These include topics such as the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic tests for autoantibodies, as well as the epidemiology, pathophysiology, and treatment of autoimmune diseases. While the journal covers a wide range of subjects, it emphasizes papers exploring the genetic, molecular biology, and cellular aspects of the field.
The Journal of Translational Autoimmunity, on the other hand, is a subsidiary journal of the Journal of Autoimmunity. It focuses specifically on translating scientific discoveries in autoimmunity into clinical applications and practical solutions. By highlighting research that bridges the gap between basic science and clinical practice, the Journal of Translational Autoimmunity aims to advance the understanding and treatment of autoimmune diseases.